Detail of Performance Analysis Table
Pharmaceutical Outcomes Portfolio
Performance Measure |
FY Targets |
Actual Performance |
Reference* |
By 2014 reduce
congestive heart
failure hospital
readmission rates
during the first six
months from 38% to
20% in those
between 65 and 85
years of age.
Outcome |
FY 2004: Establish baseline rates.
FY 2005:
Drop to 37%.
FY 2006:
Drop to 36%.
FY 2007: Drop to 34%.
FY 2008:
Drop to 32%.
FY 2009:
Drop to 30%.
FY 2010: Drop to 28%.
FY 2011:
Drop to 26%.
FY 2012:
Drop to 24%.
FY 2013:
Drop to 22%.
FY 2014:
Drop to 20%.
|
FY 2004: Completed (38%
readmissions) |
SG-1/5
HP-14/17 |
Overuse of
antibiotics is a major
cause of antibiotic
resistance. By 2014
antibiotic use in
children between the
ages of one and
fourteen should be
reduced from 0.56
per year to 0.42 per
child per year (25%)
Outcome
|
FY 2004: Establish baseline rates.
FY 2005:
2.0% drop.
FY 2006:
2.0% drop.
FY 2007: 2.0% drop.
FY 2008:
2.0% drop.
FY 2009:
2.0% drop.
FY 2010: 2.0% drop.
FY 2011:
2.0% drop.
FY 2012:
2.0% drop.
FY 2013:
2.0% drop.
FY 2014:
2.0% drop. |
Completed (0.56
per year)
|
SG-1/5
HP-14/17 |
Reduce
hospitalization for
upper
gastrointestinal
bleeding due to the
adverse effects of
medication or
inappropriate
treatment of peptic
ulcer disease, in
those between 65
and 85 year of age
from 55 per 10,000 population to 45 per
10,000. Outcome
|
FY 2004: Establish baseline rates.
FY 2005:
1.8% drop.
FY 2006:
1.8% drop.
FY 2007: 1.8% drop.
FY 2008:
1.8% drop.
FY 2009:
1.8% drop.
FY 2010: 1.8% drop.
FY 2011:
1.8% drop.
FY 2012:
1.8% drop.
FY 2013:
1.8% drop.
FY 2014:
1.8% drop. |
Completed (55
per 10,000)
|
SG-1/5
HP-14/17 |
* SG = Strategic Goal; HP = Healthy People |
Return to Exhibits
Proceed to Next Section